Cargando…

Phase 1/2 study of concurrent chemoradiotherapy with weekly irinotecan hydrochloride for advanced/recurrence uterine cancer: A multi-institutional study of Kansai Clinical Oncology Group

OBJECTIVE: Concurrent chemoradiotherapy using cisplatin was thought to be standard treatment for squamous cell carcinoma of cervix, but it had not been effective for adenocarcinoma. Concurrent chemoradiotherapy using irinotecan hydrochloride (CPT-11) had been effective for colorectal cancer, thus, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takeuchi, Satoshi, Kuroboshi, Haruo, Mori, Taisuke, Ito, Kimihiko, Kondo, Eiji, Tabata, Tsutomu, Itani, Yoshio, Kawaguchi, Ryuji, Takeuchi, Kyosuke, Soejima, Toshinori, Sasaki, Ryohei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7219098/ https://www.ncbi.nlm.nih.gov/pubmed/32410799 http://dx.doi.org/10.21147/j.issn.1000-9604.2020.02.09

Ejemplares similares

Kansai Japanese : the language of Ōsaka, Kyōto, and Western Japan
por: Tse, Peter
Publicado: (1994)

Design of Electron Beam Injection System for Laser Acceleration Experiments at JAERI-Kansai
por: Kando, M, et al.
Publicado: (1999)

Relationship Between Alcohol Drinking Pattern and Risk of Proteinuria: The Kansai Healthcare Study
Publicado: (2016)

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry
por: Nakaya, Aya, et al.
Publicado: (2018)

The Association Between Metabolically Healthy Obesity and the Risk of Proteinuria: The Kansai Healthcare Study
por: Uehara, Shinichiro, et al.
Publicado: (2018)

Blood pressure components and the risk for proteinuria in Japanese men: The Kansai Healthcare Study
por: Shibata, Mikiko, et al.
Publicado: (2017)

Irinotecan Plus Doxorubicin Hydrochloride Liposomes for Relapsed or Refractory Wilms Tumor
por: Wang, Juan, et al.
Publicado: (2021)

Box–Behnken Design of Experiments of Polycaprolactone Nanoparticles Loaded with Irinotecan Hydrochloride
por: Mahmoud, Basant Salah, et al.
Publicado: (2023)

Intensified concurrent chemoradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatment in patients with locally advanced rectal cancer
por: Klautke, G, et al.
Publicado: (2005)

Clinicopathologic features, treatment, prognosis and prognostic factors of neuroendocrine carcinoma of the endometrium: a retrospective analysis of 42 cases from the Kansai Clinical Oncology Group/Intergroup study in Japan
por: Matsumoto, Harunobu, et al.
Publicado: (2019)

Family Medicine as a Solution-oriented Medical Practice: A Letter from Kansai, Japan
por: Takenaka, Hiroaki
Publicado: (2012)

A multicenter phase I study of preoperative chemoradiotherapy with S-1 and irinotecan for locally advanced lower rectal cancer (SAMRAI-1)
por: Sato, Takeo, et al.
Publicado: (2016)

Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum
por: Nakaya, Aya, et al.
Publicado: (2021)

Lower Serum Creatinine Is a New Risk Factor of Type 2 Diabetes: The Kansai Healthcare Study
por: Harita, Nobuko, et al.
Publicado: (2009)

Serum Gamma-Glutamyltransferase, Daily Alcohol Consumption, and the Risk of Chronic Kidney Disease: The Kansai Healthcare Study
por: Shibata, Mikiko, et al.
Publicado: (2020)

Comparison of treatment outcomes of surgery and radiotherapy, including concurrent chemoradiotherapy for stage Ib2-IIb cervical adenocarcinoma patients: a retrospective study
por: Kondo, Eiji, et al.
Publicado: (2021)

MPC-04 MOLECULAR FEATURES AND CLINICAL OUTCOMES OF ELDERLY GLIOBLASTOMA PATIENTS: ANALYSES OF KANSAI NETWORK AND TCGA COHORTS
por: Fukai, Junya, et al.
Publicado: (2019)

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato‐Biliary Oncology Group
por: Matsukuma, Satoshi, et al.
Publicado: (2020)

Protective Effects of Kampo Medicines and Baicalin against Intestinal Toxicity of a New Anticancer Camptothecin Derivative, Irinotecan Hydrochloride (CPT‐11), in Rats
por: Takasuna, Kiyoshi, et al.
Publicado: (1995)

( 18)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Positive Lymph Node Endometriosis Masquerading as Lymph Node Metastasis of a Malignant Tumor
por: Akiyama, Makoto, et al.
Publicado: (2014)

TB-08 PATIENT DERIVED XENOGRAFT’S BIOBANK FROM KANSAI MOLECULAR DIAGNOSIS NETWORK FOR CENTRAL NERVOUS SYSTEM TUMORS
por: Kijima, Noriyuki, et al.
Publicado: (2019)

Projection Matrices, Generalized Inverse Matrices, and Singular Value Decomposition
por: Yanai, Haruo, et al.
Publicado: (2011)

Successful combination chemotherapy with irinotecan hydrochloride and cisplatin for primary gastric small cell carcinoma: report of a case
por: Funahashi, Hitoshi, et al.
Publicado: (2013)

Intestinal Anisakiasis Treated Successfully with Prednisolone and Olopatadine Hydrochloride
por: Toyoda, Hideki, et al.
Publicado: (2016)

Concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of the cervix in a uterus didelphys with vaginal septum
por: Kaneyasu, Yuko, et al.
Publicado: (2019)

Combined Measurement of Fasting Plasma Glucose and A1C Is Effective for the Prediction of Type 2 Diabetes: The Kansai Healthcare Study
por: Sato, Kyoko Kogawa, et al.
Publicado: (2009)

Comparison of Neoadjuvant Intraarterial Chemotherapy Versus Concurrent Chemoradiotherapy in Patients With Stage IIIB Uterine Cervical Cancer
por: Kawaguchi, Ryuji, et al.
Publicado: (2013)

Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy.
por: Tsuda, H., et al.
Publicado: (1994)

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
por: Tamaki, Yukihisa, et al.
Publicado: (2018)

Characteristics and outcomes of elderly patients with diffuse gliomas: a multi-institutional cohort study by Kansai Molecular Diagnosis Network for CNS Tumors
por: Sasaki, Takahiro, et al.
Publicado: (2018)

Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy
por: Yamaguchi, Motoko, et al.
Publicado: (2018)

UGT1A1 polymorphisms in rectal cancer associated with the efficacy and toxicity of preoperative chemoradiotherapy using irinotecan
por: Kimura, Kei, et al.
Publicado: (2018)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
por: Lee, Sung Uk, et al.
Publicado: (2013)

The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer
por: Kawaguchi, Gen, et al.
Publicado: (2015)

A “Trojan Horse” Strategy: The Preparation of Bile Acid-Modifying Irinotecan Hydrochloride Nanoliposomes for Liver-Targeted Anticancer Drug Delivery System Study
por: Zhou, Tao, et al.
Publicado: (2023)

Induction cisplatin–irinotecan followed by concurrent cisplatin–irinotecan and radiotherapy without surgery in oesophageal cancer: multicenter phase II FFCD trial
por: Michel, P, et al.
Publicado: (2006)

Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer
por: Okano, Yoshio, et al.
Publicado: (2021)

Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma
por: Xu, Guoqiang, et al.
Publicado: (2021)

Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
por: RINO, YASUSHI, et al.
Publicado: (2013)

On-Surface Modification of Copper Cathodes by Copper(I)-Catalyzed Azide Alkyne Cycloaddition and CO(2) Reduction in Organic Environments
por: Igarashi, Ryota, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7ig9joa2ihah3v2fnr3qiumpcg